Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells

Tocilizumab is a humanized monoclonal antibody that is approved for the treatment of different human inflammatory diseases, including rheumatoid arthritis and cytokine release syndrome. Tocilizumab binds to the interleukin-6 receptor (IL-6R) and thereby blocks signaling of the pro-inflammatory cytok...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokau, Juliane, Kleinegger, Florian, Garbers, Yvonne, Waetzig, Georg H., Grötzinger, Joachim, Rose-John, Stefan, Haybaeck, Johannes, Garbers, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197771/
https://www.ncbi.nlm.nih.gov/pubmed/32365119
http://dx.doi.org/10.1371/journal.pone.0232612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197771/
https://www.ncbi.nlm.nih.gov/pubmed/32365119
http://dx.doi.org/10.1371/journal.pone.0232612

Ejemplares similares